Literature DB >> 3367398

Purification and partial characterization of brain adenosine deaminase: inhibition by purine compounds and by drugs.

J J Centelles1, R Franco, J Bozal.   

Abstract

Rat brain adenosine deaminase (E.C. 3.5.4.4.) was purified 667-fold from the supernatant fraction by the following techniques: heat treatment (60 degrees C), fractionation with ammonium sulfate, column chromatography on DEAE-Sepharose, and preparative gel electrophoresis. The purified enzyme was homogeneous by the criterion of polyacrylamide disc gel electrophoresis and isoelectric focusing. Amino acid composition is given. The isoelectric point of the enzyme (5.2) was determined by isoelectric focusing on agarose. The apparent molecular weight was estimated to be 39,000 (Stokes Radius [Rs] = 27.3 A) using a calibrated Sephacryl S-300 column. The study of the influence of the temperature on the initial reaction rates allowed calculation of Ea (8.9 Kcal/mole) and delta H (5.0 Kcal/mole) values. The variation of V and Km with pH suggests the existence of a sulfhydryl group and an imidazole group in the enzyme-substrate complex. The enzyme had a Km (adenosine) of 4.5 X 10(-5) M and was inhibited by inosine, guanosine, adenine, and hypoxanthine but not by other intermediates of purine metabolism. None of the inhibitors were active as substrates. The enzyme was also inhibited by dimethyl sulfoxide and ethanol. Inhibition by ethanol can account partially for the CNS depressant effects of levels 3 and 4 of alcohol intoxication. A number of drugs having therapeutic uses such as sedative, anxiolytic, analgesic, and relaxant are modulators of the enzyme. Among these, lidoflazine, phenylbutazone, and chlordiazepoxide are the most potent as inhibitors (Ki 30, 54, and 83 microM, respectively), whereas medazepam is the most potent as activator (Ka 0.32 mM). Thus, it is concluded that some drugs that inhibit adenosine uptake also modulate adenosine deaminase activity. Besides, since the enzyme is located extracellularly [Franco et al, 1986], these drugs can modulate the physiological effects exerted by extracellular adenosine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367398     DOI: 10.1002/jnr.490190212

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  Purification and characterization of intestinal adenosine deaminase from mice.

Authors:  L S Singh; R Sharma
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

2.  Adenosine deaminase from camel tick Hyalomma dromedarii: purification and characterization.

Authors:  Tarek M Mohamed
Journal:  Exp Appl Acarol       Date:  2006-11-07       Impact factor: 2.132

3.  Purine nucleosides and nucleotides stimulate proliferation of a wide range of cell types.

Authors:  M P Rathbone; P J Middlemiss; J W Gysbers; S DeForge; P Costello; R F Del Maestro
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

4.  Transition-state variation in human, bovine, and Plasmodium falciparum adenosine deaminases.

Authors:  Minkui Luo; Vipender Singh; Erika A Taylor; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2007-05-31       Impact factor: 15.419

5.  A model for adenosine transport and metabolism.

Authors:  J J Centelles; M Cascante; E I Canela; R Franco
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

6.  Adenosine deaminase activity modulation by some street drug: molecular docking simulation and experimental investigation.

Authors:  Massoud Amanlou; Ali-akbar Saboury; Roya Bazl; Mohammad Reza Ganjali; Shokoofeh Sheibani
Journal:  Daru       Date:  2014-05-02       Impact factor: 3.117

7.  Probing inhibition mechanisms of adenosine deaminase by using molecular dynamics simulations.

Authors:  Xiaopian Tian; Ye Liu; Jingxuan Zhu; Zhengfei Yu; Jiarui Han; Yan Wang; Weiwei Han
Journal:  PLoS One       Date:  2018-11-16       Impact factor: 3.240

Review 8.  Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.

Authors:  Barbara Kutryb-Zajac; Paulina Mierzejewska; Ewa M Slominska; Ryszard T Smolenski
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

9.  Inhibition of ecto-5'-nucleotidase and adenosine deaminase is able to reverse long-term behavioural effects of early ethanol exposure in zebrafish (Danio rerio).

Authors:  Aline Haab Lutte; Julia Huppes Majolo; Rosane Souza Da Silva
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.